Indies Pharma Jamaica has reported mixed results for its second quarter ending April 30, 2025.
Net profit for the quarter dipped by nine per cent, down J$6.5 million, as revenues also declined by 10 per cent to J$270 million.
Gross profit for the three-month period came in at J$199 million, four per cent lower than the same period last year.
However, for the six-month period, the pharmaceutical firm recorded net profit of J$138.1 million, a 3.2% increase year-on-year. Gross profit also climbed to J$419 million, up 5.3%.
The company says the results reflect ongoing strategic adjustments in a competitive market.
All feeds
